LncRNA XIST improves HMGB1 expression to exacerbate DVT through regulating ROS/NF-κB pathway through sponging of miR-103a-3p, which may be its potential therapeutic target [33]. This evidence concerns the gene HMGB1 and deep vein thrombosis.